Book chapter
Endoscopic Surveillance for Neoplasia in IBD: Random Biopsy
Endoscopy in Inflammatory Bowel Disease, pp.237-250
Springer International Publishing
10/18/2014
DOI: 10.1007/978-3-319-11077-6_16
Abstract
Patients with chronic ulcerative colitis (UC) and Crohn’s colitis have an increased risk of colonic neoplasia and colorectal cancer (CRC). Although data that colonoscopic surveillance programs increase survival is lacking; it is clear that proper surveillance can identify cancer at an earlier stage. It is important to identify which patients should be screened for dysplasia and CRC. Current international guidelines vary with regards to endoscopic techniques, but providers need to be familiar with all endoscopic modalities for optimal dysplasia surveillance. In this chapter we will review the risk factors for CRC in inflammatory bowel disease (IBD), surveillance guidelines and their limitations, and surveillance techniques. For nearly half a century random biopsies using white light endoscopy had been the mainstay of colonic dysplasia surveillance, but growing evidence and rising health care costs have shifted the paradigm toward targeted, contrast enhanced, biopsy techniques.
Details
- Title: Subtitle
- Endoscopic Surveillance for Neoplasia in IBD: Random Biopsy
- Creators
- Steven Polyak - University of Iowa Hospitals and Clinics
- Resource Type
- Book chapter
- Publication Details
- Endoscopy in Inflammatory Bowel Disease, pp.237-250
- Publisher
- Springer International Publishing; Cham
- DOI
- 10.1007/978-3-319-11077-6_16
- Language
- English
- Date published
- 10/18/2014
- Academic Unit
- Internal Medicine
- Record Identifier
- 9984360048702771
Metrics
7 Record Views